Diabetic Basement Membrane Thickening Does Not Occur in Myocardial Capillaries of Transgenic Mice When Metallothionein is Overexpressed in Cardiac Myocytes

Anatomical Record

Volumn 296, Issue 3, 2013, Pages 480-487

  Velic, Ana ^a   Laturnus, Donna ^a   Chhoun, Jennifer ^a   Zheng, Shirong ^b   Epstein, Paul ^b   Carlson, Edward ^a  

^a UNIVERSITY OF NORTH DAKOTA   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

Diabetic cardiomyopathy; Electron microscopy; Myocardial capillary basement membrane; Transgenic diabetic mice

Indexed keywords

METALLOTHIONEIN; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; ENDOTHELIUM INJURY; EXTRACELLULAR MATRIX; GENE OVEREXPRESSION; GENOTYPE; HEART LEFT VENTRICLE; HEART MUSCLE CAPILLARY; HEART MUSCLE CELL; HYPERGLYCEMIA; HYPOTHESIS; MICROSCOPY; MOUSE; MYOCARDIAL CAPILLARY BASEMENT MEMBRANE THICKENING; NONHUMAN; PRIORITY JOURNAL; THICKNESS; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; BASEMENT MEMBRANE; BLOOD GLUCOSE; CAPILLARIES; CORONARY VESSELS; DIABETIC CARDIOMYOPATHIES; DISEASE MODELS, ANIMAL; GENOTYPE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; METALLOTHIONEIN; MICE; MICE, TRANSGENIC; MICROSCOPY, ELECTRON, TRANSMISSION; MYOCYTES, CARDIAC; OXIDATIVE STRESS; PHENOTYPE; REACTIVE OXYGEN SPECIES; UP-REGULATION;

ANIMALIA; FRIEND MURINE LEUKEMIA VIRUS; MUS; MUS MUSCULUS;

EID: 84873747991     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.22646     Document Type: Article

References (49)

1. Asghar O, Al-Sumnni A, Khavandi A, Wither S, Greenstein A, Heagerty AM, Malik RA. 2009. Diabetic cardiomyopathy. Clin Sci (Lond) 116:741-760.
2. Baynes J. 1991. Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-412.
3. Bell DS. 1995. Diabetic cardiomyopathy. A unique entity or a complication of coronary artery disease? Diabetes Care 18:708-714.
4. Brownlee M. 2001. Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820.
5. Brownlee M. 2005. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615-1625.
6. Brownlee M, Vlassara H, Cerami A. 1984. Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann Intern Med 101:527-537.
7. Cai L. 2006. Suppression of nitrative damage by metallothionein in diabetic heart contributes to the prevention of cardiomyopathy. Free Radic Biol Med 41:851-861.
8. Cai L, Kang YJ. 2001. Oxidative stress and diabetic cardiomyopathy: a brief review. Cardiovasc Toxicol 1:181-193.
9. Carlson EC, Audette J, Veitenheimer N, Risan J, Laturnus D, Epstein P. 2003. Ultrastructural morphometry of capillary basement membrane thickness in normal and transgenic diabetic mice. Anat Rec 271A:332-341.
10. Carlson EC, Hinds D. 1981. Native banded collagen fibrils in the glomerular mesangial matrix of normal human and laboratory animals. J Ultrastruct Res 77:241-247.
11. Carlson EC, Teiken J, Laturnus D, KC B, Berg B, Zheng S, Epstein P. Podocyte specific overexpression of metallothionein mitigates diabetic complications in the glomerular filtration barrier and glomerular histoarchitecture: a TEM stereometric analysis (in press).
12. Dische F. 1992. Measurement of glomerular basement membrane thickness and its application to the diagnosis of thin-membrane nephropathy. Arch Pathol Lab Med 116:43-49.
13. Epstein P, Overbeek P, Means A. 1989. Calmodulin-induced early-onset diabetes in transgenic mice. Cell 58:1067-1073.
14. Giacco F, Brownlee M. 2010. Oxidative stress and diabetic complications. Circ Res 107:1058-1070.
15. Goh S-Y, Cooper ME. 2008. The role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab 93:1143-1152.
16. Greenwood MD, Ressler MJ, Audette JL, Laturnus DI, Chhoun R, Teiken JM, Carlson EC. 2011. Significant retinal capillary basement membrane thickening in hyperglycemic and normoglycemic diabetic-prone (DP) BB Wistar rats. Ultrastruct Pathol 35:97-105.
17. Gundersen HJG, Osterby R. 1972. Statistical analysis of transformations leading to normal distribution of measurements of the peripheral glomerular basement membrane. J Microsc 97:293-299.
18. Ha H, Lee HB. 2000. Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucose. Kidney Int Suppl 77:S19-S25.
19. Ha H, Yu M, Choi J, Lee B. 2001. Activation of protein kinase C-delta and C-epsilon by oxidative stress in early diabetic rat kidney. Am J Kidney Dis 38:S204-S207.
20. Hirose K, Osterby R, Nozawa M, Gundersen H. 1982. Development of glomerular lesions in experimental long-term diabetes in the rat. Kidney Int 21:689-695.
21. Iglesius-De LaCruz MC, Ruiz-Torres P, Alcami J, Diez-Marques L, Ortega-Velazquez R, Chen S, Rodriguez-Puyol H. 2001. Hydrogen peroxide increases extracellular matrix mRNA through TGFβ in human mesangial cells. Kidney Int 59:87-95.
22. Jensen E, Gunderson H, Osterby R. 1979. Determination of membrane thickness distribution from orthogonal intercepts. J Microsc 115:19-33.
23. Kang YJ, Chen Y, Yu A, Voss-McCowan M, Epstein PN. 1997 Overexpression of metallothionein in the heart of transgenic mice suppresses doxorubicin cardiotoxicity. J Clin Invest 100:1501-1506.
24. Karnovsky M. 1965. A formaldehyde-glutaraldehyde fixitive for high osmololity for use in electron microscopy. J Cell Biol 35:137A-138A.
25. Kashihara N, Haruna Y, Kanwar Y. 2010. Oxidative stress in diabetic nephropathy. Curr Med Chem 17:4256-4269.
26. Li X, Cai L, Wenke F. 2007. Diabetes and metallothionein. Mini Rev Med Chem 7:761-767.
27. Liang Q, Carlson EC, Donthi RV, Kralik PM, Shen X, Epstein PN. 2002. Overexpression of metallothionein reduces diabetic cardiomyopathy. Diabetes 51:174-181.
28. Low P, Nickander K, Tritschler H. 1997. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes 46 (Suppl 2):S38-S42.
29. Mason RM, Wahab NA. 2003. Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol 14:1358-1373.
30. Nath KA, Grande J, Croatt A, Haugen J, Kim Y, Rosenberg ME. 1998. Redox regulation of renal DNA synthesis, transforming growth factorβ-1 and collagen gene expression. Kidney Int 53:367-381.
31. Nathan DM. 1993. Long-term complications of diabetes mellitus. N Engl J Med 328:1676-1685.
32. Onosaka S, Min KS, Fujita Y, Tanaka K, Iguchi S, Okada Y. 1988. High concentration of pancreatic metallothionein in normal mice. Toxicology 50:27-35.
33. Park SK, Kim J, Seomun Y, Choi J, Kim DH, Han IO, Lee EH, Chung SK, Joo CK. 2001. Hydrogen peroxide is a novel inducer of connective tissue growth factor. Biochem Biophys Res Commun 284:966-971.
34. Prabhakar S, Starnes J, Shi S, Lonis B, Tran R. 2007. Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production. J Am Soc Nephrol 11:2945-2952.
35. Ross M, Pawlina W. 2011. Histology a text and atlas. 6th ed. Philadelphia: Lippincott Williams and Wilkins. p 327-331.
36. Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. 1972. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 30:595-602.
37. Siperstein MD, Unger RH, Madison LL. 1968. Studies of muscle capillary basement membranes in normal subjects, diabetic, and prediabetic patients. J Clin Invest 47:1973-1999.
38. Teiken J, Epstein P, Carlson E. 2011. TEM stereometric analyses of glomeruli in aging OVE26 transgenic diabetic mice. Am J Nephrol 33 (Suppl 1) 8-14.
39. Tsilibary EC. 2003. Microvascular basement membranes in diabetes mellitus. J Pathol 200:537-546.
40. Venable J, Coggeshall R. 1965. A simplified lead stain for use in electron microscopy. J Cell Biol 25:407-408.
41. Viberti G, Wiseman MJ, Pinto JR, Messent J. 1994. Diabetic nephropathy. In: Kahn CR, Weir GC, editors. Joslin's diabetes mellitus. 13th ed. Philadelphia: Lea & Fibeger. p 691-737.
42. Vijayalingam S, Parthiban A, Shanmugasundaram K, Mohan V. 1996. Abnormal antioxidant status in impaired glucose tolerance and non-insulin-dependent diabetes mellitus. Diabet Med 13:715-719.
43. Vlassara H, Palace M. 2002. Diabetes and advanced glycation endproducts. J Int Med 251:87-101.
44. Wallner E, Wada J, Tramonti G, Lin S, Srivastava S, Kanwar Y. 2001. Relevance of aldo-keto reductase family members to the pathobiology of diabetic nephropathy and renal development. Renal Failure 23:311-320.
45. Wolff S, Jiang Z, Hunt J. 1991. Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radic Biol Med 10:339-352.
46. Ye G, Metreveli NS, Ren J, Epstein PN. 2003. Metallothionein prevents diabetes-induced deficits in cardiomyocytes by inhibiting reactive oxygen species production. Diabetes 52:777-783.
47. Zheng S, Carlson EC, Yang L, Kralik P, Huang Y, Epstein PN. 2008. Podocyte-specific overexpression of the antioxidant metallothionein reduces diabetic nephropathy. J Am Soc Nephrol 19:2077-2085.
48. Zheng S, Noonan W, Metreveli N, Coventry S, Kralik P, Carlson E, Epstein P. 2004. Development of late-stage diabetic nephropathy in OVE26 diabetic mice. Diabetes 53:3248-3257.
49. Ziyadeh F. 2004. Mediators of diabetic renal disease: the case for TGF-β as the major mediator. J Am Soc Nephrol 15 (Suppl 1):S55-S57.